TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers at the University Hospital of Bonn and the University of Bonn report that they converted human red blood cell precursors directly into neural stem cells in a laboratory. The cells’ epigenetic clocks shifted toward a younger molecular age, with an example from an 80-year-old donor measuring below 20 years; this is a laboratory finding, not evidence of a treatment that reverses aging in people.
Researchers at the University Hospital of Bonn and the University of Bonn have converted human red blood cell precursors directly into neural stem cells in laboratory experiments, while tracking a shift in the cells’ molecular age markers. The study reports that cells from an 80-year-old donor showed an epigenetic age below 20 years after reprogramming, but the result is a test-tube finding, not evidence that a person’s body has been rejuvenated.
The work, published in the journal Aging Cell, used transcription factors to redirect blood-cell precursors toward a neural stem-cell identity. Such factors alter which genetic instructions a cell reads, allowing researchers to change its developmental fate without changing the underlying DNA sequence. Neural stem cells can give rise to brain cells, including neurons.
The team measured age-related chemical modifications to DNA, which are used in epigenetic clocks to estimate a cell’s molecular age. According to the report, reprogramming substantially reset these markers. The researchers say the clock changes were accompanied by behavior consistent with younger cells, though the report does not establish that the cells’ full biological function or long-term safety is equivalent to that of cells from a young person.
A central feature of the approach was its pace. Rather than first turning the blood cells into pluripotent stem cells and then guiding them into neural stem cells, the team used a direct, single-step conversion. The age-marker changes unfolded gradually and could be followed for more than 100 days, providing a longer observation period than the faster, two-step approach described in earlier work.
A Longer Window on Cell-Age Changes
The result matters primarily as a research method. Because the measured rejuvenation developed over weeks, rather than happening rapidly, researchers may be able to examine which biological processes accompany the clock reset and test whether particular factors speed it up or slow it down. That could help distinguish changes in age markers from changes that affect how cells function.
The study also connects cell reprogramming with research into brain disorders associated with aging. Age is a major risk factor for neurodegenerative diseases, including Alzheimer’s, and lab-grown neural cells could help researchers investigate disease mechanisms. However, the work does not show that this method prevents, treats, or reverses Alzheimer’s or any other disease. Use in patients would require further evidence on cell quality, safety, and whether transplanted cells work as intended.
As an affiliate, we earn on qualifying purchases.
From Blood Precursors to Neural Cells
Most mature cells in the body have a specialized role, even though they share the same genetic makeup. A blood cell does not ordinarily develop into a neuron. Laboratory reprogramming uses transcription factors to change the cell’s identity by altering the genetic instructions it follows. Scientists can use this approach to generate cell types for research and to study how cells develop.
The Bonn group had previously reported that neural cells produced through related methods formed connections with existing neurons after transplantation into mouse brains. That earlier finding concerns animal experiments and is separate from the present study’s focus on epigenetic de-aging during cell conversion. Neither result, as described in the supplied report, establishes a therapy for people.
The current paper is titled “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells.” It was published in Aging Cell in 2026, with Oliver Brüstle among the researchers involved.
““In our current study, however, we focused on a different phenomenon: namely, the observation that cells become significantly rejuvenated during reprogramming.””
— Prof. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at University Hospital of Bonn
What the Lab Result Cannot Show
The reported age shift refers to epigenetic clock measurements, not a demonstration that a person’s overall biological age has fallen by decades. The source report does not provide details such as the number of donors, the full size of the effect across samples, or how consistent the result was between individuals. Those details would be needed to assess how broadly the finding applies.
It is also not yet clear how durable the clock changes are, how well the converted cells perform over the long term, or whether the process can be controlled reliably enough for any clinical use. The reported work was conducted in a test tube; it does not establish safety or benefit in humans, and the relevance of the mouse transplantation findings from earlier research should not be confused with a human trial.
Testing the Reprogramming Timeline
The researchers say the prolonged conversion process can serve as a model for testing which factors or active substances affect the rate of epigenetic change. The next research questions include whether those clock changes consistently correspond to useful cell functions, how long they persist, and whether the converted neural stem cells remain stable.
The study does not announce a clinical trial or a planned treatment. Further laboratory work and independent assessment would be needed before researchers could determine whether the method has practical value beyond studying cell aging and neural development.
Key Questions
What did the Bonn researchers do?
They used transcription factors to convert human red blood cell precursors directly into neural stem cells in laboratory experiments, then tracked changes in age-related DNA markers.
Does the result mean an 80-year-old person became biologically younger?
No. The report says cells from an 80-year-old donor had an epigenetic clock reading below 20 years after reprogramming. That measurement applies to cells in the experiment; it does not show that the donor’s body or overall health became younger.
What is different about the Bonn method?
The researchers converted blood-cell precursors directly into neural stem cells, rather than first making pluripotent stem cells and then converting those into neural stem cells. The direct process unfolded gradually and was tracked for more than 100 days.
Could this lead to an Alzheimer’s treatment?
The study may offer a model for investigating cell aging relevant to neuroscience, but it did not test an Alzheimer’s treatment or show that the process prevents or reverses disease. No clinical benefit has been established.
What remains to be tested?
Researchers need to establish how consistent and durable the clock changes are, whether they match lasting functional changes in the cells, and whether the process can be controlled safely. The reported findings are laboratory research, not a human therapy.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
